National Healthcare Properties (HLTC) AI Stock Analysis

• Market Cap: $218.89M
• Dividend Yield: N/A
• Average Volume (3M): 184.00
• Price to Earnings (P/E): ―
• Beta (1Y): -2.57
• Revenue Growth: -2.72%
• EPS Growth: 69.06%
• Country: US
• Employees: 26
• Sector: Real Estate
• Sector Strength: 53
• Industry: REIT - Healthcare Facilities
• EPS (TTM): -0.92
• Shares Outstanding: 28,412,184
• 10 Day Avg. Volume: 152
• 30 Day Avg. Volume: 184
• PEG Ratio: 0.05
• Price to Book (P/B): 0.39
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -10.66
• Enterprise Value/Market Cap: 6.97
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: -6.97
• Enterprise Value/Ebitda: 9.55
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 47 Neutral
• Price Target: $7.50 ▲(1.35% Upside)
• Action: Reiterated Date: 02/21/26
• Date: Action: Reiterated 02/21/26

The score is held down primarily by weak and volatile financial performance (persistent losses, negative/unstable cash generation, and the 2025 revenue step-down to $0), only partly offset by significant leverage reduction. Technicals are broadly neutral and governance reforms add a small positive, while valuation remains constrained by the lack of profitability and no dividend data.

Positive Factors

Balance sheet de‑leveraging

A material reduction in total debt and a lower debt-to-equity ratio materially improve financial flexibility and reduce interest burden. This durable balance sheet repair expands capacity for refinancing, opportunistic asset moves, or absorbing operating volatility over the next several quarters.

Governance reforms & board expertise

Declassification, proxy access and adding a senior audit chair strengthen shareholder rights and oversight. Enhanced governance and added capital-markets/M&A expertise support better strategic decision-making and credibility with lenders and investors over the medium term.

New credit facilities increase liquidity

A refreshed $550M financing package extending maturities to 2028 secures near-term liquidity and replaces older facilities. The arrangement provides funding optionality for operations or portfolio actions and reduces immediate refinancing pressure, bolstering stability for months ahead.

Negative Factors

Persistent losses and weak profitability

Chronic net losses and a recent negative EBITDA indicate the underlying portfolio and operations are not generating sustainable operating returns. Over the medium term this erodes equity, limits reinvestment capacity, and forces dependence on external financing for capital needs.

Severe 2025 revenue step‑down

A reported $0 revenue year signals a structural disruption—asset disposals, accounting discontinuity, or severe operational impairment—which destroys revenue visibility. That uncertainty complicates cash‑flow forecasting and investor confidence for multiple quarters.

Inconsistent and negative free cash flow

Volatile and persistently negative free cash flow reduces internal funding for maintenance and growth, raising reliance on debt and equity raises. This increases refinancing risk, limits strategic flexibility, and constrains the firm's ability to stabilize operations over the next several quarters.

National Healthcare Properties Business Overview & Revenue Model

Company Description

Healthcare Trust, Inc. is a publicly registered real estate investment trust focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on seniors housing and medical office buildings, located in the United States.

How the Company Makes Money

National Healthcare Properties generates revenue primarily through leasing its healthcare properties to operators who provide medical and residential care services. The company typically enters long-term net leases with these operators, which obligate them to cover property expenses such as maintenance, taxes, and insurance, allowing HLTC to receive consistent rental income. Additionally, HLTC may benefit from periodic rent escalations, which are built into the lease agreements, enhancing revenue growth over time. The company also strategically acquires properties that have the potential for appreciation in value, contributing to its overall earnings through capital gains. Partnerships with reputable healthcare operators and a focus on high-demand markets further strengthen its revenue model.

National Healthcare Properties Financial Statement Overview

Summary

Overall fundamentals are weak despite improved leverage. The company shows persistent net losses, EBITDA turning negative in 2024, and an anomalous 2025 revenue drop to $0 (raising operational/data continuity concerns). Offsetting this, the balance sheet de-risked materially with debt reduced from ~$1.15B (2024) to ~$381M (2025), improving debt-to-equity to ~0.63x, but cash flow remains inconsistent with free cash flow still negative in 2025.

Income Statement

Profitability is weak and volatile. From 2020–2024 the company generated steady revenue in the ~$330M–$382M range with modest growth, but net losses persisted every year (net margins negative, including ~-21% in 2023 and ~-54% in 2024). 2025 shows an extreme step-down with revenue reported at $0 and a large gross loss, which makes the latest year look severely impaired and raises data/operational continuity concerns. EBITDA was positive in 2020–2023, turned negative in 2024, and the company has not shown a clear path to consistent earnings.

Balance Sheet

Balance sheet leverage improved meaningfully in the latest year, but overall risk remains moderate. Total debt fell sharply from about $1.15B in 2024 to ~$381M in 2025, driving debt-to-equity down from ~1.68x to ~0.63x, which is a clear positive for financial flexibility. However, equity also trended down versus earlier years (from ~$1.03B in 2021 to ~$600M in 2025), and the business has produced negative returns on equity in prior years, signaling that profitability has not supported the capital base.

Cash Flow

Cash generation is inconsistent and recently pressured. Operating cash flow swung from positive in 2020–2023 to deeply negative in 2024, then back to slightly positive in 2025 (~$7M). Free cash flow was positive in 2020–2021, roughly breakeven in 2022–2023, then materially negative in 2024 and remained negative in 2025 (about -$22M). While the return to positive operating cash flow is constructive, the continued free-cash-flow deficit and history of large cash flow swings limit confidence in funding stability.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	0.00	353.79M	345.93M	335.85M	329.36M
Gross Profit	-218.90M	132.65M	128.13M	122.40M	123.54M
EBITDA	82.02M	-22.36M	76.87M	53.76M	42.59M
Net Income	-71.07M	-189.70M	-72.30M	-79.62M	-85.18M
Balance Sheet
Total Assets	1.71B	1.95B	2.15B	2.18B	2.21B
Cash, Cash Equivalents and Short-Term Investments	57.62M	21.65M	46.41M	53.65M	59.74M
Total Debt	380.95M	1.15B	1.18B	1.12B	1.09B
Total Liabilities	1.11B	1.26B	1.24B	1.18B	1.17B
Stockholders Equity	600.06M	684.56M	894.15M	992.64M	1.03B
Cash Flow
Free Cash Flow	-21.77M	-101.75M	-773.00K	302.00K	19.81M
Operating Cash Flow	6.95M	-79.85M	21.62M	28.30M	38.88M
Investing Cash Flow	69.81M	63.97M	-62.82M	-41.78M	-47.92M
Financing Cash Flow	-42.40M	-1.35M	55.97M	4.64M	4.08M

National Healthcare Properties Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 7.40
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HLTC, the sentiment is Positive. The current price of 7.4 is below the 20-day moving average (MA) of 7.62, below the 50-day MA of 7.53, and below the 200-day MA of 7.86, indicating a neutral trend. The MACD of 0.05 indicates Positive momentum. The RSI at 50.28 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HLTC.

National Healthcare Properties Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
STRW	75 Outperform	$167.94M	21.45	50.04%	4.62%	29.76%	22.76%
CHCT	66 Neutral	$488.29M	220.80	0.46%	12.08%	3.40%	-240.85%
Sector *	65 Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%
UHT	64 Neutral	$605.21M	33.68	10.55%	7.51%	0.68%	-1.34%
DHC	54 Neutral	$1.64B	―	-15.78%	0.80%	4.10%	8.96%
HLTC	47 Neutral	$218.89M	-3.07	-11.41%	―	-2.72%	69.06%

National Healthcare Properties Corporate Events

National Healthcare Properties Accelerates Governance Reforms, Adds Director

On January 9, 2026, National Healthcare Properties, Inc. implemented a series of governance and structural changes, including amending its rights agreement to accelerate the expiration of its common share purchase rights to January 12, 2026, after which the rights ceased to be outstanding. Also on January 9 and 12, 2026, the board moved to declassify itself under Maryland law so that all directors will stand for annual election from the 2026 annual meeting, adopted new bylaws that tighten procedures for shareholder nominations, incorporate SEC universal proxy rules, introduce proxy access for long-term shareholders with at least 3% ownership, and remove a prior director qualification requirement. The board further consolidated the former Nominating and Corporate Governance Committee into a newly named Compensation and Corporate Governance Committee to cut costs and streamline oversight, and broadened its opt-out from the Maryland Business Combination Act to exempt business combinations with any party, potentially facilitating strategic transactions. Separately, on January 12, 2026, the company appointed veteran financial executive Scott Humphrey as an independent director and chair of the audit committee, adding extensive capital markets, M&A and governance expertise to support NHP’s growth strategy in healthcare real estate.

The most recent analyst rating on (HLTC) stock is a Hold with a $7.50 price target. To see the full list of analyst forecasts on National Healthcare Properties stock, see the HLTC Stock Forecast page.

National Healthcare Properties Secures New Credit Agreement

On December 11, 2025, National Healthcare Properties, Inc., along with its Operating Partnership and certain subsidiaries, entered into a new credit agreement with Wells Fargo Bank and other lenders. This agreement includes a $400 million senior unsecured revolving credit facility and a $150 million senior unsecured term loan facility, replacing a previous loan agreement from 2019. The new facilities, which mature in 2028, are intended for general corporate purposes and allow for potential increases in lending commitments. The agreement imposes various financial covenants and conditions, with the possibility of prepayment without penalty.

The most recent analyst rating on (HLTC) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on National Healthcare Properties stock, see the HLTC Stock Forecast page.